Autonomix Medical (AMIX) Registration filing summary

Offering details and pricing

• Registration statement filed for the issuance and sale, from time to time, of common stock, preferred stock, debt securities, warrants, purchase contracts, and units under Rule 415, allowing for delayed or continuous offerings.

• Includes an at-the-market (ATM) offering of up to $2.1 million in common stock under an agreement with Ladenburg Thalmann & Co. Inc.

• Estimated offering expenses include SEC registration and FINRA filing fees of $30,620 and $30,500, respectively; other expenses to be detailed in future prospectus supplements.

Underwriters and syndicate

• Ladenburg Thalmann & Co. Inc. is named as the sales agent for the ATM offering.

Management team and governance

• CEO and President: Brad Hauser; CFO: Trent Smith; Executive Chair: Walter Klemp; Executive Vice Chair: Lori Bisson; Directors include Jonathan Foster, David Robins, and Christopher Capelli.